The rate of venous thromboembolism after knee bone marrow concentrate procedures: should we anticoagulate?

PURPOSE: Intra-articular injections of autologous, minimally manipulated, cell therapies such as bone marrow concentrate (BMC) to treat knee osteoarthritis (OA) may delay or prevent future total knee arthroplasty (TKA). Arthroplasty has the known and substantial risk of venous thromboembolism (VTE)...

Descripción completa

Detalles Bibliográficos
Autores principales: Centeno, Christopher J., Money, Brandon T., Dodson, Ehren, Stemper, Ian, Steinmetz, Neven J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492566/
https://www.ncbi.nlm.nih.gov/pubmed/35844014
http://dx.doi.org/10.1007/s00264-022-05500-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492566/
https://www.ncbi.nlm.nih.gov/pubmed/35844014
http://dx.doi.org/10.1007/s00264-022-05500-3

Ejemplares similares